OpenNashEarnings

Health Care · NYSE: HIMS

Hims & Hers earnings: results, call transcripts & KPI history

2 quarters · fiscal year ends December · next results expected around 22 Feb 2027

Investor relations ↗SEC filings ↗KPIs as CSV

Latest: Q3 2026

Revenue was $890.4 million for the third quarter of 2026, up 49% year-over-year, with a net loss of $33.0 million and Adjusted EBITDA of $82.4 million.

Hims & Hers grew third-quarter revenue 49% to $890.4 million, its second straight quarter of faster growth. International revenue more than quadrupled, while US revenue rose 21%. Profitability fell sharply: gross margin dropped to 57% from 74%, and the company posted a net loss of $33.0 million versus net income of $15.8 million a year earlier. Subscribers reached 2,788 thousand, up 13%.

Read the Q3 2026 summary →

Quarters

KPI history

Revenue$890.4M+48.6% y/yQ3 2026
Q4 2024: $481.1M (worked out from the annual figure)Q4 ’24$481.1MQ1 2025: $586.0MQ1 ’25$586.0MQ2 2025: $544.8MQ2 ’25$544.8MQ3 2025: $599.0MQ3 ’25$599.0MQ4 2025: $617.8M (worked out from the annual figure)Q4 ’25$617.8MQ1 2026: $608.1MQ1 ’26$608.1MQ2 2026: $753.2MQ2 ’26$753.2MQ3 2026: $890.4MQ3 ’26$890.4M

Fourth quarter worked out from the annual figure.

Data
Q4 2024$481.1M *
Q1 2025$586.0M
Q2 2025$544.8M
Q3 2025$599.0M
Q4 2025$617.8M *
Q1 2026$608.1M
Q2 2026$753.2M
Q3 2026$890.4M
Diluted EPS (GAAP)-$0.14Q3 2026
Q1 2025: $0.20Q1 ’25$0.20Q2 2025: $0.17Q2 ’25$0.17Q3 2025: $0.06Q3 ’25$0.06Q1 2026: -$0.40Q1 ’26-$0.40Q2 2026: -$0.37Q2 ’26-$0.37Q3 2026: -$0.14Q3 ’26-$0.14
Data
Q1 2025$0.20
Q2 2025$0.17
Q3 2025$0.06
Q1 2026-$0.40
Q2 2026-$0.37
Q3 2026-$0.14

Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.

Operating margin-7.4%−9.4 pts y/yQ3 2026
Q4 2024: 3.9%Q4 ’243.9%Q1 2025: 9.9%Q1 ’259.9%Q2 2025: 4.9%Q2 ’254.9%Q3 2025: 2.0%Q3 ’252.0%Q4 2025: 1.5%Q4 ’251.5%Q1 2026: -12.9%Q1 ’26-12.9%Q2 2026: -12.9%Q2 ’26-12.9%Q3 2026: -7.4%Q3 ’26-7.4%
Data
Q4 20243.9%
Q1 20259.9%
Q2 20254.9%
Q3 20252.0%
Q4 20251.5%
Q1 2026-12.9%
Q2 2026-12.9%
Q3 2026-7.4%
Free cash flow$26.0M−67.3% y/yQ3 2026
Q4 2024: $59.5MQ4 ’24$59.5MQ1 2025: $50.1MQ1 ’25$50.1MQ2 2025: -$69.5MQ2 ’25-$69.5MQ3 2025: $79.4MQ3 ’25$79.4MQ4 2025: -$2.6MQ4 ’25-$2.6MQ1 2026: $53.1MQ1 ’26$53.1MQ2 2026: -$68.2MQ2 ’26-$68.2MQ3 2026: $26.0MQ3 ’26$26.0M
Data
Q4 2024$59.5M
Q1 2025$50.1M
Q2 2025-$69.5M
Q3 2025$79.4M
Q4 2025-$2.6M
Q1 2026$53.1M
Q2 2026-$68.2M
Q3 2026$26.0M

Operating cash flow minus capital expenditure, from cash flow statements.

Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
Revenue$481.1Md$586.0M$544.8M$599.0M$617.8Md$608.1M$753.2M$890.4M
Gross margin76.8%73.5%76.4%73.8%71.9%65.2%63.8%57.2%
Operating income$18.6Md$57.9M$26.7M$11.8M$9.2Md-$78.3M-$97.2M-$66.1M
Operating margin3.9%9.9%4.9%2.0%1.5%-12.9%-12.9%-7.4%
Net income$26.0Md$49.5M$42.5M$15.8M$20.6Md-$92.1M-$86.3M-$33.0M
Diluted EPS—$0.20$0.17$0.06—-$0.40-$0.37-$0.14
Operating cash flow$86.4Md$109.1M-$19.1Md$148.7Md$61.3Md$89.4M-$35.9Md$65.4Md
Capital expenditure$26.9Md$59.0M$50.4M$69.3M$63.9Md$36.3M$32.3M$39.4M
Free cash flow$59.5M$50.1M-$69.5M$79.4M-$2.6M$53.1M-$68.2M$26.0M

From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.

10-Q and 10-K filings